Pharmacokinetic Analysis Dataset Study Description This master protocol included multiple drugs of interest (DOIs) being studied. The primary objective of this study was to evaluate the pharmacokineti

NIAID Data Ecosystem10

Adverse events in all cycles of treatment for all patients receiving at least one cycle of treatment in the CSV and MSV groups.

临床试验不良事件

药物安全性评估

Adverse events in all cycles of treatment for all patients receiving at least one cycle of treatment in the CSV and MSV groups.

NIAID Data Ecosystem20

All adverse events (AEs) and treatment-related AEs, listed by system organ class.

临床试验不良事件

药物安全性评估

(n = 11 in the G-CSF group, n = 15 in the placebo group). Incidences of events were not significantly different between both groups (Fisher's Ex

NIAID Data Ecosystem10

Profiling of D-PA Induced Idiosyncratic Drug Reactions

资源简介：

相关数据集